Piper Jaffray rated Overweight The Advisory Board Company (NASDAQ: ABCO) on 11/24/2009, when the stock price was $12.47. Since then, The Advisory Board Company has gained 298.07% as of 01/11/2016's recent price of $49.62.
If you would have followed this Piper Jaffray's recommendation on ABCO, you would have gained 298.07% of your investment in 2239 days.

The Advisory Board Company and its subsidiaries provides best practices research, analysis, executive education and leadership development, business intelligence tools, and installation support to hospitals, health systems, pharmaceutical and biotech companies, health care insurers, medical device companies, and universities and other education institutions through discrete programs. The Company?s program offerings focus on business strategy, operations, and general management issues. Best practices research identifies, analyzes, and describes specific management initiatives, strategies, processes that produce the best results in solving common problems or challenges. The Company serve approximately 2,800 members. Each of its programs provides members with assistance in addressing one of three primary issue sets: business strategy, operations and general management issues.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.

Marked as spam